Page last updated: 2024-10-30

metformin and Parodontosis

metformin has been researched along with Parodontosis in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"To compare the risk of gingival and periodontal diseases (GPD) between ever users and never users of metformin in patients with type 2 diabetes mellitus."8.12Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study. ( Tseng, CH, 2022)
"To compare the risk of gingival and periodontal diseases (GPD) between ever users and never users of metformin in patients with type 2 diabetes mellitus."4.12Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study. ( Tseng, CH, 2022)
" Qualitative synthesis also suggests an apparently dose-response relationship and increased benefit when administered alone."2.58Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review. ( Estrugo Devesa, A; Jané-Salas, E; López-López, J; Saka Herrán, C, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Tseng, CH1
Neves, VCM1
Satie Okajima, L1
Elbahtety, E1
Joseph, S1
Daly, J1
Menon, A1
Fan, D1
Volkyte, A1
Mainas, G1
Fung, K1
Dhami, P1
Pelegrine, AA1
Sharpe, P1
Nibali, L1
Ide, M1
Saka Herrán, C1
Jané-Salas, E1
Estrugo Devesa, A1
López-López, J1

Reviews

1 review available for metformin and Parodontosis

ArticleYear
Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
    Oral oncology, 2018, Volume: 85

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Case-Control Studies; Cohort Studi

2018

Trials

1 trial available for metformin and Parodontosis

ArticleYear
Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine.
    Journal of translational medicine, 2023, 10-10, Volume: 21, Issue:1

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Management; Humans; Hypoglycemic Agents;

2023

Other Studies

1 other study available for metformin and Parodontosis

ArticleYear
Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Periodontal Diseases; Retrospecti

2022